← Scroll for more →
Financial Statements — LBRX
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 283.11 | 320.68 | 250.17 | 269.74 |
| Short-term Investments | 44.68 | 44.96 | 45.04 | 44.74 |
| Total Current Assets | 355.30 | 389.07 | 308.43 | 316.40 |
| Property, Plant & Equipment | 2.20 | 1.53 | 1.58 | 1.64 |
| Total Non-current Assets* | 6.39 | 4.41 | 4.50 | 4.35 |
| Total Assets | 361.69 | 393.48 | 312.93 | 320.75 |
| Accounts Payable | 3.49 | 7.12 | 2.13 | 2.59 |
| Total Current Liabilities | 23.56 | 10.91 | 7.44 | 6.65 |
| Total Non-current Liabilities* | 5.78 | 3.88 | 4.18 | 3.88 |
| Total Liabilities | 29.35 | 14.79 | 11.62 | 10.53 |
| Retained Earnings | (200.18) | (148.58) | (129.53) | (118.06) |
| Total Stockholder Equity | 332.35 | 378.69 | 301.31 | 310.22 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Research & Development | 44.15 | 14.65 | 8.48 | 2.42 |
| Selling, General & Admin | 9.77 | 7.46 | 5.39 | 2.83 |
| Total Operating Expenses | 53.92 | 22.10 | 13.87 | 5.25 |
| Pretax Income | (51.60) | (19.05) | (11.47) | (3.56) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (51.60) | (19.05) | (11.47) | (3.56) |
| Basic EPS | (1.71) | (0.67) | 3.13 | (0.61) |
| Diluted EPS | (1.71) | (0.67) | 3.13 | (0.61) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Operating Cash Flow | (37.63) | (23.29) | (18.10) | (17.10) |
| Capital Expenditures | 0.36 | 0.03 | 0.04 | 0.01 |
| Free Cash Flow* | (37.99) | (23.32) | (18.14) | (17.12) |
| Investing Cash Flow | 0.09 | (0.03) | (0.04) | (39.85) |
| Financing Cash Flow | (0.02) | 93.83 | (1.17) | 303.73 |
← Scroll for more columns →
* Derived from reported values